Is Generative AI The Future of Equitable Healthcare?
Read Now!
Online
Log in
Explore
Drug Knowledgebase
Start here! Dig into essential drug information
Advanced Exploration
Categories & ATC Classifications
Pathways
Drug Reactions
Drug Classification
Drug Targets
Advanced Search
Target Sequence
Spectra Search
Pharmaco-omics
Chemical Structure
Data Library
Academic Downloads
Interaction Checker
Get More
Navigate to
DrugBank.com
to check out our commercial products, use cases and more!
DrugBank For Clinical Software
Clinical API
Clinical intelligence tool for your software
Features
Drug Search
Customizable drug search options
Drug-Drug Interaction Checker
Search for drug interactions with our API
Drug Allergy
Get drug allergy and cross sensitivities info
US Drug Labels
Integrate drug manufacturer information
Log in
Drugs
Targets
Pathways
Indications
Drugs
Drugs
Targets
Pathways
Indications
Log in or create an account for full access to this data.
Create Account
Log in
Metastatic Renal Pelvis Urothelial Carcinoma
Drug Trials
Drug
Drug Name
Drug Description
Drug
Drug Name
Target
Type
Drug
Drug Name
Phase
Status
Count
DB13007
Enfortumab vedotin
1
Recruiting
1
DB12147
Erdafitinib
1
Recruiting
1
DB00041
Aldesleukin
2
Withdrawn
1
DB11595
Atezolizumab
2
Active Not Recruiting
2
DB11945
Avelumab
2
Recruiting
1
DB00531
Cyclophosphamide
2
Withdrawn
1
DB08871
Eribulin
2
Active Not Recruiting
1
DB01073
Fludarabine
2
Withdrawn
1
DB11997
Interleukin-7
2
Active Not Recruiting
1
DB06186
Ipilimumab
2
Active Not Recruiting
1
DB17107
Lifileucel
2
Withdrawn
1
DB09035
Nivolumab
2
Active Not Recruiting
1
DB09035
Nivolumab
2
Recruiting
2
DB09037
Pembrolizumab
2
Recruiting
1
DB09037
Pembrolizumab
2
Withdrawn
1
DB00571
Propranolol
2
Recruiting
1
DB14851
Relatlimab
2
Recruiting
1
DB06273
Tocilizumab
2
Active Not Recruiting
1
DB11595
Atezolizumab
3
Active Not Recruiting
1
DB11945
Avelumab
3
Active Not Recruiting
2
DB00112
Bevacizumab
3
Completed
1
DB08875
Cabozantinib
3
Active Not Recruiting
1
DB14547
Chloride ion
3
Completed
1
DB00515
Cisplatin
3
Completed
1
DB01248
Docetaxel
3
Recruiting
1
DB11714
Durvalumab
3
Active Not Recruiting
1
DB08871
Eribulin
3
Recruiting
1
DB00441
Gemcitabine
3
Completed
1
DB00441
Gemcitabine
3
Recruiting
1
DB09035
Nivolumab
3
Active Not Recruiting
1
DB01229
Paclitaxel
3
Recruiting
1
DB09037
Pembrolizumab
3
Active Not Recruiting
1
DB12257
Platinum
3
Completed
1
DB12893
Sacituzumab govitecan
3
Recruiting
1